Literature DB >> 16230383

Gene expression profiling of human sarcomas: insights into sarcoma biology.

Kristin Baird1, Sean Davis, Cristina R Antonescu, Ursula L Harper, Robert L Walker, Yidong Chen, Arthur A Glatfelter, Paul H Duray, Paul S Meltzer.   

Abstract

Sarcomas are a biologically complex group of tumors of mesenchymal origin. By using gene expression microarray analysis, we aimed to find clues into the cellular differentiation and oncogenic pathways active in these tumors as well as potential biomarkers and therapeutic targets. We examined 181 tumors representing 16 classes of human bone and soft tissue sarcomas on a 12,601-feature cDNA microarray. Remarkably, 2,766 probes differentially expressed across this sample set clearly delineated the various tumor classes. Several genes of potential biological and therapeutic interest were associated with each sarcoma type, including specific tyrosine kinases, transcription factors, and homeobox genes. We also identified subgroups of tumors within the liposarcomas, leiomyosarcomas, and malignant fibrous histiocytomas. We found significant gene ontology correlates for each tumor group and identified similarity to normal tissues by Gene Set Enrichment Analysis. Mutation analysis done on 275 tumor samples revealed that the high expression of epidermal growth factor receptor (EGFR) in certain tumors was not associated with gene mutations. Finally, to further the investigation of human sarcoma biology, we have created an online, publicly available, searchable database housing the data from the gene expression profiles of these tumors (http://watson.nhgri.nih.gov/sarcoma), allowing the user to interactively explore this data set in depth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16230383     DOI: 10.1158/0008-5472.CAN-05-1699

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  130 in total

1.  Systematic therapy for unresectable or metastatic soft-tissue sarcomas: past, present, and future.

Authors:  Sherif S Morgan; Lee D Cranmer
Journal:  Curr Oncol Rep       Date:  2011-08       Impact factor: 5.075

2.  PDGF receptor alpha is an alternative mediator of rapamycin-induced Akt activation: implications for combination targeted therapy of synovial sarcoma.

Authors:  Alan L Ho; Shyamprasad Deraje Vasudeva; Marick Laé; Tsuyoshi Saito; Violetta Barbashina; Cristina R Antonescu; Marc Ladanyi; Gary K Schwartz
Journal:  Cancer Res       Date:  2012-07-10       Impact factor: 12.701

3.  Feasibility of using gene expression analysis to study canine soft tissue sarcomas.

Authors:  Jennifer A Mahoney; Julie C Fisher; Stacey A Snyder; Marlene L Hauck
Journal:  Mamm Genome       Date:  2010-11-13       Impact factor: 2.957

Review 4.  [Sarcoma gene signatures].

Authors:  F Chibon; J-M Coindre
Journal:  Pathologe       Date:  2011-02       Impact factor: 1.011

5.  Molecular biology and therapeutics in musculoskeletal oncology.

Authors:  Theresa A Guise; Regis O'Keefe; R Lor Randall; Richard M Terek
Journal:  J Bone Joint Surg Am       Date:  2009-03-01       Impact factor: 5.284

Review 6.  Role of genetic and molecular profiling in sarcomas.

Authors:  Scott M Norberg; Sujana Movva
Journal:  Curr Treat Options Oncol       Date:  2015-05

7.  Heterogeneity in intratumor correlations of 18F-FDG, 18F-FLT, and 61Cu-ATSM PET in canine sinonasal tumors.

Authors:  Tyler J Bradshaw; Stephen R Bowen; Ngoneh Jallow; Lisa J Forrest; Robert Jeraj
Journal:  J Nucl Med       Date:  2013-09-16       Impact factor: 10.057

8.  EWS/FLI-1 induces rapid onset of myeloid/erythroid leukemia in mice.

Authors:  Enrique C Torchia; Kelli Boyd; Jerold E Rehg; Chunxu Qu; Suzanne J Baker
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

Review 9.  The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Kathy Q Cai; Michael F Ochs; Burton Eisenberg; Min Huang; Margaret von Mehren; Andrew K Godwin
Journal:  Cell Cycle       Date:  2008-10-07       Impact factor: 4.534

Review 10.  Gene translocations in musculoskeletal neoplasms.

Authors:  Balaji Krishnan; Gaurav Khanna; Denis Clohisy
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.